Gary Darland
23Patents
6h-index
14Co-inventors
62Inventor score
Filing activity: Apr 30, 1999 → Mar 18, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6210701A | Medical food for treating inflammation-related diseases | Human Necessities | 46 | Expired |
| US7270835B2 | Compositions that treat or inhibit pathological conditions associated with inflammatory response | Human Necessities | 29 | Expired |
| US6352712B1 | Dietary supplements for treating fatigue-related syndromes | Human Necessities | 28 | Expired |
| US7431948B2 | Compositions that treat or inhibit pathological conditions associated with inflammatory response | Human Necessities | 27 | Expired |
| US8142819B2 | Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response | Human Necessities | 14 | Expired |
| US6602517B2 | Dietary supplements for treating inflammation-related diseases | Human Necessities | 8 | Expired |
| US7790205B2 | Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response | Human Necessities | 6 | Expired |
| US8557306B2 | Compositions that treat or inhibit pathological conditions associated with inflammatory response | Human Necessities | 4 | Active |
| US7901713B2 | Inhibition of COX-2 and/or 5-LOX activity by fractions isolated or derived from hops | Human Necessities | 4 | Active |
| US7666449B2 | Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity | Human Necessities | 3 | Active |
| US7919125B2 | Modulation of inflammation by hops fractions and derivatives | Human Necessities | 3 | Active |
| US7820206B2 | Modulation of inflammation by hops fractions and derivatives | Human Necessities | 3 | Active |
| US7794757B2 | Modulation of inflammation by hops fractions and derivatives | Human Necessities | 3 | Active |
| US7815944B2 | Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment of prevention of gastric toxicity | Human Necessities | 3 | Active |
| US7722903B2 | Modulation of inflammation by hops fractions and derivatives | Human Necessities | 3 | Expired |
| US7811610B2 | Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity | Human Necessities | 3 | Expired |
| US7807203B2 | Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity | Human Necessities | 3 | Active |
| US8410178B2 | CIS 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-derivatives, substantially enantiomerically pure compositions and methods | Chemistry; Metallurgy | 2 | Active |
| US8257754B2 | Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response | Human Necessities | 1 | Active |
| US8486457B2 | Compositions that treat or inhibit pathological conditions associated with inflammatory response | Human Necessities | 0 | Active |
| US8829056B2 | Cis 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl) cyclopent-2-en-1-one derivatives, substantially enantiomerically pure compositions and methods | Chemistry; Metallurgy | 0 | Active |
| US8168234B2 | Compositions that treat or inhibit pathological conditions associated with inflammatory response | Human Necessities | 0 | Active |
| US8410179B2 | Cis, 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-derivatives, substantially enantiomerically pure compositions and methods | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.